Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non-exclusive Discount Contract According To Section 130a (8) Sgb V On Pharmaceuticals With The Active Ingredient Axitinib (atc Code: L01ek01). 2025-11-10
Germany Completion Of A Non-exclusive Discount Contract According To Section 130a (8) Sgb V To Medicinal Products With The Active Ingredient Octreotide, In A Dosage Form With Delayed Release Behavior (atc Code: H01cb02). 2025-11-10
Germany Completion Of Non-exclusive Discount Agreements According To Section 130a (8) Sgb V (open House Model) 2025-11-10
Tunisia Acquisition Of Cochlear Implants 2025-11-10
Portugal Acquisition Of Alpha-1 1000mg Inj Iv Antitripsin, Alpha-1 4000mg /160ml Inj Iv And Alpha-1 5000mg /200ml Inj Iv Antitripsin 2025-11-10
Portugal Requalification Of The Hospitalization Of Psychiatry Located On Dpsm Faro Floor 2 2025-11-10
Germany Completion Of Non -exclusive Discount Agreement According To Section 130a (8) Sgb V For Active Ingredients (drugs) - Vv 84 2025-11-10
Germany Completion Of Non-exclusive Discount Agreements According To § 130 A (8) Sgb V From 01.07.2025 2025-11-10
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2025-11-11
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2025-11-11
Whats app